Generalized vasculitis, thrombocytopenia, and transient lymphoproliferative disorder caused by idiopathic mixed cryoglobulinemia

American Journal of the Medical Sciences

Volumn 326, Issue 1, 2003, Pages 47-50

  Schwartzenberg, Shmuel ^b   Levo, Yoram ^a   Averbuch, Mordechai ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Leukocytoclastic vasculitis; Mixed cryoglobulinemia; Purpura; Thrombocytopenia

Indexed keywords

AGED; ARTICLE; CANCER; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; LABORATORY TEST; LEUKOCYTOCLASTIC VASCULITIS; LUNG DISEASE; LYMPHOPROLIFERATIVE DISEASE; MALE; PURPURA; RECURRENT DISEASE; SKIN BIOPSY; SKIN DISEASE; SPLEEN DISEASE; THROMBOCYTOPENIA; TREATMENT PLANNING; VASCULITIS;

EID: 0038638243     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200307000-00007     Document Type: Article

References (19)

1. Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.
2. Jenette JC, Falk RJ. Small vessel vasculitis. N Engl J Med 1997;21:1512-23.
3. Bussel J, Cines D. Immune thrombocytopenic purpura, neonatal alloimmune thrombocytopenia and posttransfusion purpura. In: Hoffman R, Benz EJ, Sanford JS, editors. Hematology: basic principles and practice. New York: Churchill Livingstone; 2000. p. 2096-102.
4. Wintrobe MM, Buell MV. Hyperproteinemia associated with multiple myeloma. Bull Johns Hopkins Hosp 1933;52:156.
5. Kallemuchikkal U, Gorevic PD. Evaluation of cryoglobulins. Arch Pathol Lab Med 1999;123:119-25.
6. Gorevic PD. Cryoglobulins and cryoglobulinemia. In: Austen KF, Frank MF, Atkinson JP, editors. Samter's immunologic diseases. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1002-22.
7. La Civita L, Zignego AL, Monti AL, et al. Mixed cryoglobulinemia as a possible paraneoplastic disorder. Arthritis Rheum 1995;38:1859-60.
8. Crosbie OM, Alexander GJM. Cryoglobulinemia in HCV infection: coming in from the cold. Gut 1999;45:8-9.
9. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus. N Engl J Med 1992;327:1490-5.
10. Bloch KJ. Cryoglobulinemia and hepatitis C virus. N Engl J Med 1992;327:1521-2.
11. Ferri CF, Zignego AL. Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr Opin Rheumatol 2000;12:53-60.
12. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C infection. N Engl J Med 1993;328:465-70.
13. Pozzato G, Mazzaro C, Crovatto M. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994;84:3047-52.
14. De Re V, De Vita S, Marzotto A, et al. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int J Cancer 2000;87:211-6.
15. Frankel AH, Singer DR, Winearls CG. Type II essential mixed cryoglobulinemia: presentation, treatment and outcome in 13 patients. Q J Med 1992;82:101-24.
16. Miescher PA, Huang YP, Izui S. Type II cryoglobulinemia. Semin Hematol 1995;32:80-5.
17. Tarantino A, De Vecchi A, Montagnino G, et al. Renal disease in essential mixed cryoglobulinaemia. Long-term follow-up of 44 patients. Q J Med 1981;50:1-30.
18. Vassilopoulus D, Calabrese LH. Hepatitis C virus and vasculitis. Arthritis Rheum 2002;46:585-97.
19. Zaja F, De Vita S, et al. Rituximab for the treatment of type II mixed cryoglobulinemia. Arthritis Rheum 2002;46:2252-4.